Ekso Bionics (NASDAQ:EKSO) Coverage Initiated at StockNews.com

Research analysts at StockNews.com began coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a report issued on Saturday. The brokerage set a “hold” rating on the stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $10.00 target price on shares of Ekso Bionics in a research note on Tuesday, July 30th.

Ekso Bionics Trading Up 2.0 %

EKSO stock opened at $1.04 on Friday. The company has a market capitalization of $19.18 million, a PE ratio of -1.32 and a beta of 1.45. Ekso Bionics has a one year low of $0.75 and a one year high of $3.13. The company’s 50 day moving average price is $1.10 and its two-hundred day moving average price is $1.15. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.77 and a current ratio of 2.42.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.02). Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. The business had revenue of $4.95 million for the quarter, compared to analysts’ expectations of $5.34 million. During the same period last year, the business posted ($0.31) earnings per share. As a group, analysts predict that Ekso Bionics will post -0.42 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Ekso Bionics stock. Kent Lake Capital LLC boosted its stake in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 322.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 596,050 shares of the company’s stock after acquiring an additional 454,892 shares during the period. Kent Lake Capital LLC owned 3.28% of Ekso Bionics worth $811,000 at the end of the most recent reporting period. Institutional investors own 6.42% of the company’s stock.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.